Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic
BackgroundGestational diabetes mellitus (GDM), a severe pregnancy disorder, is a temporary form of diabetes that occurs during gestation. Astragaloside IV (AS IV), a natural and effective composition of Astragalus membranaceus, shows pharmacological effects against diabetes. On the contrary, the eff...
Saved in:
| Main Authors: | Fengge Wang, Yongning Zhu, Hua Shu, Xiaoyun Zhang, Liting Duan, Dongmei Man, Yanping Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1431240/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Astragaloside IV alleviated bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and fecal metabolism
by: Huichao Wang, et al.
Published: (2025-04-01) -
Gut Microbiota and Alzheimer Disease
by: Lester Raymundo Dominguez Huarcaya
Published: (2025-01-01) -
Integrated Metabolome and Microbiome Analysis Reveals the Regulatory Effects of Fermented Soybean Meal on the Gut Microbiota of Late Gestation
by: Yantao Li, et al.
Published: (2025-05-01) -
GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART 1. GUT MICROBIOTA, AGE AND SEX
by: D. A. Kashtanova, et al.
Published: (2015-08-01) -
Astragaloside IV: a potential nemesis for gastric cancer
by: Chao Hu, et al.
Published: (2025-07-01)